MICA reports profit on lower revenues

Article

The turnaround effort undertaken by Medical Imaging Centers ofAmerica continues to show signs of success (SCAN 3/15/95). TheSan Diego-based imaging services firm showed a profit for itssecond quarter (end-June), although revenues were down.

The turnaround effort undertaken by Medical Imaging Centers ofAmerica continues to show signs of success (SCAN 3/15/95). TheSan Diego-based imaging services firm showed a profit for itssecond quarter (end-June), although revenues were down.

Consolidated medical services revenues were $10.3 million,compared to $12.9 million in the second quarter of 1994, a dropof 20%. MICA posted net income of $551,000 for the quarter, comparedto a net loss of $230,000 in the same period last year.

Income from continuing operations for the second quarter was$335,000, compared to a loss from continuing operations in thesame period last year of $388,000. Discontinued operations includeMICA's Chicago-based ultrasound and nuclear medicine business,which the company has sold to Diagnostic Health Services.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.